Precigen, Inc. Skyrocketed

Precigen, Inc. (PGEN:NASDAQ) soared at $2.94, a gain of 58.9%. On Fri, Aug 15, 2025, PGEN:NASDAQ hit a New 2-Week High of $2.94. The stock got featured on our News Catalysts scanner on Fri, Aug 15, 2025 at 03:15 PM in the 'MISCELLANEOUS' category. From Fri, Aug 01, 2025, the stock recorded 60.00% Up Days and 45.45% Green Days
About Precigen, Inc. (PGEN:NASDAQ)
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs, builds, and regulates gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.
Top 10 Gainers:
- SRAX, Inc. (SRAX:NASDAQ), 138.1%
- Perfect Moment Ltd. Common Stock (PMNT:NYSEMKT), 91.56%
- SRx Health Solutions Inc. (SRXH:NYSEMKT), 84.64%
- IO Biotech, Inc. (IOBT:NASDAQ), 68.75%
- Precigen, Inc. (PGEN:NASDAQ), 58.92%
- Matinas BioPharma Holdings, Inc. (MTNB:NYSEMKT), 43.03%
- Pioneer Power Solutions, Inc. (PPSI:NASDAQ), 39.87%
- Sunrun Inc. (RUN:NASDAQ), 32.82%
- Fossil Group, Inc. (FOSL:NASDAQ), 31.91%
- flyExclusive, Inc. (FLYX:NYSEMKT), 28.31%